Reuters reported the DOJ settlement with Mylan Inc for a 2006 lawsuit over illegal Medicare and Medicaid reimbursements to pharmacists and other healthcare providers. As part of the settlement, Mylan subsidiary Dey has agreed to pay $280 million. Mylan bought the drug division in 2007 from Merck KGaA, after the lawsuit was filed. Under the acquisition agreement, Merck is responsible for paying the full amount of the settlement as well as all costs related to reimbursement lawsuits involving Dey.
DOJ Settlement, Merck will pay $280 million
by Ray Mullman ⋅